MiR-141-3p inhibits the activation of nuclear factor kappa B (NF-κB) signaling by directly targeting tumor necrosis factor receptor-associated factor 5 and 6, consequently suppressing the invasion, migration, and bone metastasis of PC cells [88]. The gene discussed is NFKB1; the disease is pachyonychia congenita.